Viyash Scientific Subsidiary Executes SPA for BioForLife Italia Acquisition

Viyash Scientific Limited's step-down subsidiary, Alivira Animal Health Limited, Ireland, has executed a Sale and Purchase Agreement (SPA) to acquire 100% of BioForLife Italia S.r.l. The base consideration is approximately EUR 16.976 million, comprising EUR 15 million at closing and EUR 1.976 million as retained/deferred consideration. The deferred consideration mechanism has been revised and is linked to contractual continuation conditions. Transaction completion is subject to Italian FDI/Golden Power clearance and other SPA conditions. This disclosure confirms the execution of definitive transaction documentation.